Related by context. All words. (Click for frequent words.) 55 clinical 53 dexanabinol 52 genomic biomarker 51 CA9 SCAN 51 clinical pharmacology studies 51 NP2 Enkephalin 50 Hedgehog inhibitor 49 lomitapide 49 fosbretabulin 49 radiographic outcomes 49 DFCI 49 haematological cancers 49 OvaRex MAb 49 Hedgehog agonist 48 riociguat 48 p# inhibitor 48 Phase #b/#a 48 rBChE 48 ELACYT 48 Aurora kinase inhibitors 48 ALTROPANE 48 ReN# 48 pharmacological therapies 48 ACTILON 48 PEARL SC 48 DXL# 48 phase IIb clinical 48 randomized Phase IIb 47 AQUAVAN R 47 RhuDex 47 incyclinide 47 tezampanel NGX# 47 vidofludimus 47 Phase IIb III 47 placebo controlled clinical 47 thetreatment 47 pharmacogenetic testing 47 vivo pharmacology 47 tumor immunology 47 recurrent herpes labialis 47 canakinumab 47 Neurostep TM 47 Phase IIb clinical trials 47 GLP toxicology studies 47 Pyridorin 47 ONCONASE R 47 Genasense ® 47 prospective longitudinal 47 GRN# 47 ataluren 47 ganaxolone 46 Zenvia ™ 46 Androxal TM 46 CBLC# 46 PDE# inhibitors 46 pharmacokinetic pharmacodynamic 46 EDEMA3 trial 46 Zevalin consolidation 46 TRV# [001] 46 ADAGIO study 46 Alequel 46 clevidipine 46 NTDDS platform 46 Phase 1a clinical 46 intravenous methylnaltrexone 46 Cloretazine R 46 AZX# 46 confirmatory Phase III 46 BrachySil TM 46 analgesic efficacy 46 GCP compliant 46 pharmaco 46 OvaRex 46 Ophena 46 blinded randomized controlled 46 PRIMO CABG 46 schizophrenia CIAS 46 TACI Ig 46 PFO migraine 46 Dacogen injection 45 Cloretazine ® 45 ICA # 45 clincial 45 gepirone ER 45 OHR/AVR# 45 Hedgehog antagonist 45 non nucleoside 45 diabetic neuropathic pain 45 NEUGENE antisense 45 lorvotuzumab mertansine 45 Proellex TM 45 anti angiogenic agents 45 cystinosis patients 45 faropenem 45 IIa clinical trials 45 ASONEP 45 BETAS 45 budesonide MMX Phase III 45 oral talactoferrin 45 therapeutic armamentarium 45 immunotherapeutic vaccine 45 GAMMAGARD 45 DAPT 45 Lixivaptan 45 preclinical pharmacology 45 CURE AF 45 Azedra 45 vernakalant hydrochloride 45 Voraxaze ™ 45 Sequenom CMM 45 Hyphanox 45 enzastaurin 45 huN# DM1 45 Aplidin 45 CRLX# 45 MyVax ® 45 Phase Ib study 45 Cloretazine R VNP#M 45 Neuradiab 45 preclinically 45 Posidur 45 pivotal bioequivalence 45 clinically 45 rindopepimut 45 Aurexis 45 International Nasdaq PRAI 45 tolevamer 45 INCB# [001] 45 MAGE A3 ASCI 45 antithrombotic therapy 45 Altastaph 45 vinca alkaloid 45 phase IIb III 45 Vascular Wrap 45 XP #L 44 entinostat 44 TLK# 44 confirmatory clinical 44 TriGrid 44 GGF2 44 TRIST study 44 prospective multicenter study 44 phase III ACCLAIM 44 phase IIb study 44 phase IIa clinical 44 BLA filing 44 efficacy tolerability 44 CARE HF 44 RhuDex ® 44 QOPI 44 recurrent glioma 44 Phase Ib clinical 44 Itopride 44 tremelimumab 44 postoperative ileus POI 44 pharmacologic treatments 44 bardoxolone 44 pertuzumab 44 pain palliation 44 HQK 44 oral methylnaltrexone 44 MGd 44 phase IIa 44 cannabinor 44 INOmax R 44 Desmoteplase 44 treating neuropathic pain 44 Fibrin Pad 44 IIa clinical 44 invasive candidiasis 44 TBC# 44 sacral nerve stimulation 44 multicenter Phase II 44 Bioaccelerate compounds under 44 CINQUIL 44 eosinophilic asthma 44 Rheos System 44 Gag polymorphisms 44 bicifadine 44 BNC# 44 constipation OIC 44 Tectin TM 44 HuMax EGFr 44 liprotamase 44 viral kinetic 44 QTinno TM 44 Nonclinical 44 senicapoc 44 Zoraxel 44 investigational HCV polymerase 44 oral prodrug 44 vivo preclinical 44 tecarfarin 44 Squalamine 44 Sernova Cell Pouch 44 HGS# 44 optimal dosing regimens 44 CB2 selective receptor agonist 44 ruxolitinib 44 JAK2 inhibitors 44 aerosolized KL4 surfactant 44 Phase Ib IIa clinical 44 Glybera R 44 BRIM3 43 fidaxomicin Phase 3 43 immatics 43 therapeutic regimens 43 pharmacodynamic PD 43 psychometrically sound 43 eniluracil 43 IMA# 43 novel therapeutic antibodies 43 preclinical efficacy 43 CHAMPION PCI 43 VTE prevention 43 OncoVEX 43 Corlux 43 orally inhaled migraine 43 NTx ® -# 43 Phase 2a clinical trials 43 opioid analgesia 43 Zybrestat 43 JAK2 inhibitor 43 ospemifene 43 ganetespib 43 isoform selective 43 Virulizin ® 43 postapproval 43 Chrysalin 43 PREGNANT Study 43 pharmacokinetic PK study 43 BEMA TM Fentanyl 43 personalized immunotherapy 43 ChronVac C R 43 thorough QT 43 epigenetic therapies 43 cartilage regeneration 43 radiolabeled TM# 43 PRECISE trial 43 clinically relevant 43 phase IIIb 43 everolimus eluting stents 43 Glenveigh 43 REG1 43 OnDose TM 43 luliconazole 43 favorable pharmacokinetic profile 43 Edwards SAPIEN valve 43 Archexin 43 CLORETAZINE TM VNP#M 43 EGS# 43 clinical trials 43 Meta analyzes 43 GEM OS1 43 IIa trials 43 Azedra TM 43 trastuzumab DM1 T DM1 43 Elocalcitol 43 ESBA# 43 OncoVEX GM CSF 43 oncologic 43 forodesine 43 guideline concordant 43 EchoCRT 43 ancrod 43 Phase IIIb clinical 43 Phase III randomized controlled 43 SJTRI 43 EOquin TM 43 AFRS TM 43 LibiGel ® Phase III 43 clinicaltrials 43 ACRIN 43 DDP# 43 QLT# 43 adipiplon 43 bardoxolone methyl 43 therapeutic monoclonal antibody 43 RE LY ® 43 safinamide 42 Clinical 42 Phase IIB 42 bioequivalency 42 preclinical pharmacokinetic 42 postoperative ileus 42 Plicera 42 visilizumab 42 vosaroxin 42 perfusion CT 42 Sulonex 42 Proxinium TM 42 MEND CABG II 42 LEUKINE 42 elacytarabine 42 Zemplar Capsules 42 haematologic 42 randomized blinded 42 Vascular Wrap TM 42 JAK inhibitor 42 ostarine 42 davunetide intranasal AL 42 bosutinib 42 multicenter clinical trials 42 PSN# [002] 42 biased ligand 42 Bicifadine 42 Phase III TRIST 42 pharmacotherapeutic 42 Neuradiab TM 42 CRMD# 42 Lauren Silvernail 42 adipose derived stem cell 42 SNT MC# 42 SILENOR 42 velafermin 42 viral kinetics 42 Stimuvax R 42 solid organ transplantation 42 TMS Therapy 42 zanolimumab 42 galiximab 42 antiangiogenic agents 42 Cx# [002] 42 rALLy clinical trial 42 Cutanea 42 EmbraceAC 42 GSK# [002] 42 Phase 1b trial 42 SPARLON 42 INS# [001] 42 opioid induced bowel dysfunction 42 tonabersat 42 Val HeFT 42 Inc. Nasdaq NLTX 42 AA Amyloidosis 42 oxymorphone ER 42 human microdosing 42 LibiGel Phase III 42 alemtuzumab MS 42 Capesaris 42 personalized cellular immunotherapy 42 rheumatologic 42 CB1 antagonists 42 cangrelor 42 clinically meaningful 42 Amigal 42 Factor VIIa 42 Oasmia 42 postmarketing surveillance 42 MAXY VII 42 AERx iDMS 42 GEM OS2 42 talactoferrin 42 clinical trial 42 Sudhir Agrawal D.Phil 42 BACcel 42 predictive biomarkers 42 intranasal formulation 42 briakinumab 42 Pharma Medica 42 Panzem R NCD 42 Ophena TM 42 Phase IIb trial 42 nonclinical studies 42 metaanalysis 42 metastatic sarcomas 42 MAXY alpha 42 Intraject 42 phase IIb trial 42 CytoFab ™ 41 dermaPACE TM 41 biostatistical 41 obatoclax 41 Phase III VISTA 41 OMAPRO 41 oral PTH 41 unblinding 41 Neo Kidney Augment 41 vemurafenib 41 Phase 1b clinical 41 EXPAREL 41 lumiliximab 41 OXi# 41 NeuroFlo 41 Numoda 41 punctal plug delivery 41 revision hip arthroplasty 41 Aethlon Hemopurifier R 41 phase IIb 41 UPLYSO 41 phase Ib 41 null responder 41 Oral NKTR 41 ASCEND HF 41 opioid induced constipation 41 radezolid 41 rALLy 41 Fx #A 41 reslizumab 41 neratinib 41 elotuzumab 41 psychopharmacological 41 Rezular 41 Vasogen Celacade TM 41 NSABP 41 Ereska 41 deforolimus 41 TRO# 41 multicenter trials 41 TKM ApoB 41 dextofisopam 41 RSD# oral 41 Prodarsan ® 41 alvespimycin 41 Mipomersen 41 placebo controlled Phase III 41 pharmacologic 41 AQ4N 41 StemEx R 41 immunological diseases 41 IRX 2 41 subcutaneous formulation 41 Dataflow Manager 41 KL4 surfactant 41 BST CarGel R 41 clincal 41 teriflunomide 41 ADVANCE PD 41 Veronate 41 Acute Coronary Syndromes ACS 41 Combo Stent 41 Prednisporin TM 41 MabThera rituximab 41 Aryplase 41 Phase 2b study 41 patient 41 oral antiviral 41 neuroimmunology 41 pharmacoeconomic 41 CCX# 41 oral ridaforolimus 41 Durata 41 Alocrest 41 systemic RNAi 41 lenalidomide Revlimid R 41 Altrazeal TM Silver 41 Phase IIb trials 41 microRNA profiling 41 investigational therapies 41 Phase IIa trial 41 Mepact 41 M6G 41 BR.# 41 noninfectious uveitis 41 ProSavin 41 Adlea 41 ColorectAlert TM 41 Entereg R 41 AZILECT ® 41 Huntexil 41 leading oral taxane 41 EP #R 41 AVADO 41 Ceflatonin 41 Rasagiline 41 CDRD 41 prospective multicenter 41 eculizumab therapy 41 NTDDS 41 FFR measurements 40 eTag assays 40 OvaRex R 40 Onalta 40 pediatric rheumatology 40 recombinant PSMA vaccine 40 prelicensure 40 CIPN 40 preclinical toxicology 40 Mpex 40 including eniluracil ADH 40 Phase Ib 40 biomarker identification 40 MGN# 40 IL# PE#QQR 40 LibiGel ® 40 CINTREDEKIN BESUDOTOX 40 Cloretazine 40 Memryte 40 BioMAP 40 Hemopurifier 40 Cogane 40 ViaCyte 40 Cancidas 40 Phase IIa clinical 40 RE LY 40 hematological malignancy 40 TELINTRA 40 B. Lynne Parshall 40 Clonicel 40 Instanyl 40 REALITY Trial 40 BRAF inhibitor 40 Zenvia Phase III 40 dirucotide MBP# 40 YONDELIS 40 PRT# 40 OvaRex ® MAb 40 Valdoxan 40 SUTENT ® 40 HeFH 40 SEPET TM 40 SUCCEED trial 40 EECP ® therapy 40 Surfaxin LS 40 CCR9 antagonist 40 Phase IIIB IV 40 pediatric bipolar disorder 40 Fentanyl TAIFUN R 40 ENMD # 40 farletuzumab 40 MyVax personalized immunotherapy 40 KRN# 40 GLP toxicology 40 MYDICAR 40 Prostate Px + 40 Panzem R 40 PDE4 inhibitor 40 cytopathology 40 EndoTAG TM 40 Proxinium 40 AMPAKINE CX# 40 gefitinib Iressa 40 HEOR 40 GLPG# 40 almorexant 40 Hepatocellular Carcinoma HCC 40 CYT# potent vascular disrupting 40 SinuNase TM 40 kidney urologic 40 Dynogen 40 severe hypercholesterolemia 40 hematology microbiology 40 daclizumab 40 biliary tract cancer 40 pharmacodynamic properties 40 double blinded randomized 40 nicotinic alpha 7 40 GED aPC 40 BioSante LibiGel Phase III 40 rHuPH# 40 PANVAC VF 40 Lymphoseek ® 40 torezolid phosphate 40 preclinical 40 Wellstat 40 pharmacogenetic tests 40 Annamycin 40 alvimopan 40 selective androgen receptor modulator 40 sulodexide 40 Manja Bouman CEO 40 Cethrin 40 daptomycin 40 EDEMA3 40 HCD# [002] 40 midstage clinical 40 BEXXAR 40 Puricase PEG uricase 40 procedural sedation 40 Cethromycin 40 dirucotide 40 Trofex 40 rALLy trial 40 CaPre TM 40 tubulin inhibitor 39 pharmacokinetic PK 39 Solazed 39 MERLIN TIMI 39 novel oral anticoagulant 39 OraTest R 39 rt PA 39 ABSORB trial 39 YONDELIS R 39 celgosivir 39 Ketotransdel 39 MOZOBIL 39 HORIZONS AMI trial 39 coronary intervention 39 Viprinex 39 pharmacotherapies 39 Toraymyxin TM 39 midstage trials 39 interventional neuroradiology 39 bioabsorbable stent 39 VITAL Trial 39 Phase IIb clinical 39 Nanobody 39 Electronic Brachytherapy 39 omacetaxine 39 KuDOS 39 BioDisc 39 microplasmin Phase III 39 PsychoGenics 39 cardio renal 39 mecarbil 39 registrational 39 isavuconazole 39 IIa trial 39 PORxin TM 39 Quinamed 39 pharmacogenetic 39 Avastin adjuvant 39 predictive toxicology 39 intranasal insulin 39 balsalazide tablet 39 AcelRx 39 pharmacokinetic 39 Nanobodies ® 39 PEG PAL 39 Phase 2a clinical 39 punctal plug drug 39 Urocortin 2 39 tiapamil 39 subcutaneous immunoglobulin 39 interventional cardiac 39 Triapine R 39 PHX# 39 IMC #B 39 Phase 2b clinical 39 AzaSite Plus 39 Zavesca R 39 cardiotoxic effects 39 blood clot dissolver 39 oral RSD# 39 CLARITY study 39 LymphoStat B 39 Ceflatonin R 39 Aerosurf 39 Aganocide 39 catheter occlusion 39 Phase #/#a 39 Soliris TM eculizumab 39 gastroenterological 39 Facet Solutions 39 postmarket surveillance 39 ALN TTR# 39 refractory angina 39 RIGScan CR 39 Cellegesic 39 PK PD 39 REMINYL ® 39 micafungin 39 aesthetic dermatological conditions 39 HERmark assay 39 ophthalmology dermatology cardiovascular disease 39 IND enabling 39 TOCOSOL Paclitaxel 39 temsirolimus Torisel ® 39 translational medicine 39 rxRNA 39 INFUSE ® 39 EC Cysteamine 39 sunitinib malate 38 Dr Gillian Braunold 38 dacetuzumab 38 angiographic outcomes 38 AVN# [001] 38 GI motility disorders 38 convenient dosing regimen 38 Dalbavancin 38 budesonide foam 38 OLYMPIA registry 38 tolerability profiles 38 ToleroMune 38 Aethlon Hemopurifier ® 38 Medifacts 38 MYCAMINE 38 ularitide 38 Ketotransdel TM 38 acute decompensated heart 38 Phase Ib II 38 CytoFabTM 38 methylnaltrexone 38 Actilon 38 Perforomist ™ Inhalation Solution 38 ALGRX 38 ORENCIA R 38 Phase 2a trial 38 Fibrocaps 38 TKM PLK1 38 tasimelteon 38 oral taxane 38 Removab 38 candidate TNFerade biologic 38 CardioFit 38 Exherin TM 38 INTERCEPT platelets 38 Syndax Pharmaceuticals Inc. 38 ATIR TM 38 Phase III clinical 38 tipranavir 38 Celator 38 cardiometabolic 38 HIV integrase inhibitors 38 TYZEKA 38 targeted radiotherapeutic 38 R#/MEM # 38 Allovectin 7 38 Vilazodone 38 OZURDEX ® 38 Fabry Disease 38 RE COVER 38 Cardio Vascu Grow 38 tezampanel 38 TQT studies 38 preclinical studies 38 Pervasis 38 cancer immunotherapies 38 stage hypoxia activated 38 maribavir 38 Prednisporin 38 RESOLUTE clinical 38 pharmacoepidemiology 38 CAPHOSOL 38 MEND CABG 38 Simulect 38 COR Analyzer 38 omecamtiv mecarbil 38 AeroLEF TM 38 Opexa 38 CoFactor 38 EGEN 37 clinicians 37 COU AA 37 prospective nonrandomized 37 SYNTAX trial 37 Targeted Chemotherapy 37 Zingo TM 37 www.nextrials.com 37 QTinno 37 cGMP manufacture 37 injectable formulations 37 Serdaxin 37 candidate CRLX# 37 Prodarsan R 37 CR# vcMMAE 37 non alcoholic steatohepatitis 37 Zavesca r 37 efficacy 37 HORIZONS AMI 37 pharmacokinetic studies 37 Tovaxin ® 37 Sigma Tau SpA 37 palifosfamide 37 Phase III trials 37 Cortex AMPAKINE 37 interventional therapies 37 Novolimus 37 EOquin 37 Phase III clinical trials 37 prostone 37 kinase profiling 37 PK PD modeling 37 Adlea TM 37 Phase 2b clinical trials 37 psychiatry neurology 37 Myocet 37 HGS ETR1 37 tolerability 37 XmAb 37 Jean Pierre Sommadossi Ph.D. 37 Phase 2b trial 37 POSIDUR TM 37 evaluating Nexavar 37 pivotal Phase III 37 ProTrials Research 37 DermTech International 37 Phase Ia 37 fostamatinib 37 IND submission 37 Intarcia 37 eprotirome 37 tafamidis 37 HspE7 37 Stedivaze 37 bioanalysis 37 Preclinical 37 Evoltra ® 37 NEXTERONE 37 NATRECOR ® 36 PD2i ® 36 candidates Dyloject TM 36 nonclinical 36 Tragara Pharmaceuticals Inc. 36 Neovasc Reducer 36 PD2i Analyzer 36 endocrinology oncology 36 FFR measurement 36 Kendle NASDAQ KNDL 36 elagolix 36 PROSTVAC TM 36 Nanobody ® 36 anidulafungin 36 ticagrelor Brilinta 36 renal anemia 36 ALN PCS 36 atherosclerosis regression 36 Phase #b/#a trial 36 fibrin sealant 36 rhC1INH 36 clazosentan 36 AERx 36 metabolite identification 36 RELOVAIR ™ 36 relapsed multiple myeloma 36 neurology cardiology 36 clinician 36 FVIIa 36 PORxin TM platforms 36 mechanical thrombectomy 36 R#/MEM 36 molecular pathology 36 TNFerade TM 36 ALN HTT 36 PREOS R 36 PLK1 SNALP 36 Zemiva TM 36 cerebral oximetry 36 resuscitative measures 36 Rhucin R 36 patients 36 randomized clinical trials 36 ZFP Therapeutic 36 Firazyr ® 36 PMA submission 36 pharmacogenetics 36 herpetic keratitis 36 RGB # 36 oncology virology 36 hematologic oncology 36 Acute Decompensated Heart Failure 36 transplantation immunology 36 BioLife enabling 36 clinical pharmacology 36 neurosurgical 36 Phase IIa trials 36 oxypurinol 36 Catabasis 36 aripiprazole Abilify 36 FavId 36 Referenced EEG ® 36 gynecologic procedures 36 NEUMUNE 35 Neo Kidney Augment ™ 35 acute ischemic stroke 35 pharmacoeconomics 35 NovaBay Aganocide compounds 35 DPX Survivac 35 data management Clintrial 35 dermatologic 35 diagnostic prognostic 35 ENDEAVOR IV 35 Vicinium TM 35 COMFORT II 35 XL# SAR# 35 Phase IIa 35 Phase IIb 35 crofelemer 35 pediatric 35 renin inhibition 35 randomized trials 35 Celacade TM 35 Liprotamase 35 invivodata 35 rEEG 35 trastuzumab DM1 35 Renal Cell Carcinoma RCC 35 sodium thiosulfate STS 35 VEGF Trap 35 postmarket safety 35 clinical informatics 35 Exelixis compounds 35 Plenaxis TM 35 CIP ISOTRETINOIN 35 rFactor XIII 35 molecular imaging radiopharmaceutical 35 Tolerx 35 lexidronam injection 35 oncology dermatology 35 oncology 35 eTag assay 35 Referenced EEG 35 lintuzumab 34 prehospital 34 intravenous acetaminophen 34 translational research 34 Phase IIIb study 34 IV acetaminophen 34 Sulonex TM 34 Altrazeal ® 34 KineMed 34 Q#IR 34 AssureRx 34 urology oncology 34 biologic 34 THALOMID 34 abstracts summarizing 34 GeneSightRx 34 UltiMAb R technology 34 FOLOTYN ® 34 EECP R 34 zileuton CR 34 molecular profiling 34 PICSO ® 34 teduglutide 34 torcetrapib atorvastatin 34 pharmacodynamic 34 investigational 34 Periowave TM Photodisinfection System 34 pharmacogenomic testing 34 Nasulin 34 PREOS 34 Kendle Nasdaq KNDL 34 HCV polymerase inhibitor 34 external counterpulsation systems 33 XmAb ® 33 pharmacology 33 Phase IIIb 33 interventional pulmonology 33 Cleviprex TM clevidipine 33 therapeutic 33 Icatibant 33 topically applied SEPA 33 IMPROVE HF 33 cardiothoracic surgical 33 ADME 33 AspenBio 33 REMOXY ® 33 interprofessional education 33 recombinant factor VIIa 33 inhalation toxicology 33 bioanalytical laboratories 33 Xcytrin R 33 biomarker 33 plaque excision 32 HealthCore 32 Accelovance 32 OPTTX 32 renal 32 Sunrise Ambulatory Care 32 GI endoscopy 32 vilazodone 32 peri operative 32 anticoagulation 32 inVentiv Clinical 32 Med eMonitor System 32 oncology neurology 32 CellerateRx 32 Xanodyne 32 therapeutics 32 INxin TM 32 retrospective observational study 32 oncology cardiology 32 RelayHealth securely processes 32 Phase 1b 31 Personalized Oncology 31 eRT 31 clinically validated 31 pharmacovigilance 31 biomarker discovery 31 immunology 31 Clinical Research 31 diagnostic 31 UltiMAb ® 31 ZEVALIN ® 31 Vion Pharmaceuticals 31 indicates cardio circulatory 31 ACORN CRO 31 REVEAL Registry 31 companion diagnostics 31 Tarek Sherif CEO 30 EECP ® 30 OFIRMEV 30 Nivestim 30 perinatal 30 perioperative 30 pharmacogenomics 30 Metricath Gemini 30 pediatric intensivists 29 ePRO 29 Clinical Trial 28 ophthalmology 28 therapeutic antibody 28 biologics 28 physicians 28 Clinical Trials 26 Medidata Rave 26 molecular oncology 25 gastroenterology